Universal Vision Biotechnology Co (ROCO:3218) Net Income (Continuing Operations) : NT$1,064 Mil (TTM As of Dec. 2023)

View and export this data going back to 2004. Start your Free Trial

What is Universal Vision Biotechnology Co Net Income (Continuing Operations)?

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Universal Vision Biotechnology Co's Net Income (Continuing Operations) for the three months ended in Dec. 2023 was NT$254 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Dec. 2023 was NT$1,064 Mil.

Universal Vision Biotechnology Co Net Income (Continuing Operations) Historical Data

The historical data trend for Universal Vision Biotechnology Co's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Universal Vision Biotechnology Co Net Income (Continuing Operations) Chart

Universal Vision Biotechnology Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Income (Continuing Operations)

Get a 7-Day Free Trial

191.72

484.15

610.66

868.11

1,064.02

Universal Vision Biotechnology Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Net Income (Continuing Operations)	Get a 7-Day Free Trial															246.40	271.82	267.02	270.74	254.44

Universal Vision Biotechnology Co Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$1,064 Mil.

Universal Vision Biotechnology Co (ROCO:3218) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Universal Vision Biotechnology Co Net Income (Continuing Operations) Related Terms

Thank you for viewing the detailed overview of Universal Vision Biotechnology Co's Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.

Universal Vision Biotechnology Co (ROCO:3218) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Universal Vision Biotechnology Co Ltd (ROCO:3218) » Definitions » Net Income (Continuing Operations)

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 3-1, Yuanyuan Street, 4th Floor, Nangang District, Taipei, TWN, 115

Website

https://www.uvb.com.tw

Universal Vision Biotechnology Co Ltd provides eye treatment and related medical services in Taiwan. It also provides optical devices, glasses, lens and other vision aid products, optometric services, sales and leasing of medical devices, providing of hospital management and technical consultancy services.

Universal Vision Biotechnology Co (ROCO:3218) Headlines

No Headlines